| Drug Name: | Bexarotene (153559-49-0) |
|---|---|
| PubChem ID: | 82146 |
| SMILES: | CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C |
| InchiKey: | NAVMQTYZDKMPEU-UHFFFAOYSA-N |
| Therapeutic Category: | Anticarcinogenic Agents, Antineoplastic Agents, Protective Agents |
| Molecular Weight (dalton) | : | 348.486 |
| LogP | : | 6.10372 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 1 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 37.3 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category